In The Lancet Microbe, Hin Chu and colleagues1 compare the replication capability of severe acute respiratory syndrome coronavirus (SARS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 25 different cell lines, including nine of human origin, using quantitative RT-PCR. The susceptibility of different cell lines to SARS-CoV and SARS-CoV-2 offers valuable information for future work on antiviral compounds, vaccine strain production, investigation of cellular interactors, and host responses to infection.
No takes yet. Share an insight, caveat, or question.
Valeria Cagno (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: